Funder
Memorial Sloan-Kettering Cancer Center
Subject
Care Planning,Health Policy,Oncology (nursing),Radiology, Nuclear Medicine and imaging
Reference35 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians. 2021;71:7-33.
2. Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data;Weg;Advances in radiation oncology.,2019
3. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy;Miralbell;Int J Radiat Oncol Biol Phys,2012
4. Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer;Zelefsky;International Journal of Radiation Oncology Biology Physics,2019
5. Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies;Jackson;International Journal of Radiation Oncology*Biology*Physics.,2019